Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Transplantation

• Publication date

  2000-03-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-200003150-00027PMID 10755535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of immunosuppression in lymphoma formation

  2004cited by this paper
• Literature abstracts

  2004cited by this paper
• Cyclosporine induces cancer progression by a cell-autonomous mechanism

  1999cited by this paper
• Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8

  1999cited by this paper
• Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient.

  1998cited by this paper
• The roles of human viruses in the pathogenesis of lymphoma.

  1998cited by this paper
• The roles of human viruses in the pathogenesis of lymphoma.

  1998cited by this paper
• Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.

  1998cited by this paper
• Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome.

  1998cited by this paper
• Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.

  1998cited by this paper
• Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients.

  1998cited by this paper
• Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants.

  1998cited by this paper
• Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens.

  1998cited by this paper
• BEAM chemotherapy and autologous haemopoietic progenitor cell transplantation as front‐line therapy for high‐risk patients with diffuse large cell lymphoma

  1997cited by this paper
• Classification of the posttransplant lymphoproliferative disorders: from the past to the present.

  1997cited by this paper
• Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop.

  1997cited by this paper
• Epstein-Barr Virus DNA recombination and loss in sporadic Burkitt's lymphoma.

  1996cited by this paper
• Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?

  1996cited by this paper
• The new lymphotropic herpesviruses (HHV-6, HHV-7, HHV-8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: an overview.

  1996cited by this paper
• Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.

  1995cited by this paper
• Aggressive treatment for postcardiac transplant lymphoproliferation.

  1995cited by this paper
• Risk of neoplasia in renal transplant patients.

  1995cited by this paper
• Clinical problem solving. The girl with the curl.

  1995cited by this paper
• Involvement of the cyclin‐dependent kinase‐4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukaemia

  1995cited by this paper
• Bc16/Laz3 rearrangements in post‐transplant lymphoproliferative disorders

  1995cited by this paper
• Molecular pathogenesis of non-Hodgkin lymphoma: a clinical perspective.

  1995cited by this paper
• Post‐transplant lymphoproliferative disorders with genetic abnormalities commonly found in malignant tumours

  1995cited by this paper
• The Girl with the Curl

  1995cited by this paper
• Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease.

  1994cited by this paper
• Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma.

  1994cited by this paper
• Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype.

  1994cited by this paper
• A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

  1994cited by this paper
• Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation.

  1994cited by this paper
• Detection of immunoglobulin heavy-chain gene rearrangements by Southern blot analysis: recommendations for optimal results.

  1993cited by this paper
• Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma.

  1993cited by this paper
• Idarubicin in the initial treatment of adults with acute lymphoblastic leukemia: the effect of drug schedule on outcome.

  1993cited by this paper
• Establishment and characterization of a new granulocyte-macrophage colony-stimulating factor-dependent and interleukin-3-dependent human acute myeloid leukemia cell line (GF-D8).

  1993cited by this paper
• Posttransplantation lymphoproliferative disorders.

  1993cited by this paper
• P-VABEC: a prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphoma.

  1993cited by this paper
• Post‐transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease

  1992cited by this paper
• Neurological symptoms and coma associated with doxorubicin administration during chronic cyclosporin therapy.

  1992cited by this paper
• The changing pattern of posttransplant malignancies.

  1991cited by this paper
• Detection of Epstein-Barr virus genomes in AIDS related lymphomas: sensitivity and specificity of in situ hybridisation compared with Southern blotting.

  1991cited by this paper
• All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment.

  1991cited by this paper
• Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression.

  1991cited by this paper
• Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients.

  1990cited by this paper
• High incidence of Epstein-Barr virus genomes in Hodgkin's disease.

  1990cited by this paper
• Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.

  1989cited by this paper
• Molecular genetic analysis of lymphoid tumors arising after organ transplantation.

  1989cited by this paper
• The diagnosis and treatment of posttransplant lymphoproliferative disorders.

  1988cited by this paper
• The diagnosis and treatment of post transplant lymphoproliferative disorders

  1988cited by this paper
• Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment.

  1985cited by this paper
• Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation.

  1985cited by this paper
• Effective treatment of advanced multiple myeloma refractory to alkylating agents.

  1984cited by this paper
• Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

  1984cited by this paper
• Toxicity and response criteria of the Eastern Cooperative Oncology Group

  1982cited by this paper
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

  1981cited by this paper
• Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.

  1981cited by this paper
• Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients.

  1981cited by this paper
• Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients.

  1981cited by this paper
• Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs.

  1979cited by this paper
• Acute leukemia and immunosupressive drug use: a review of patients undergoing immunosuppressive therapy for non-neoplastic diseases.

  1979cited by this paper
• Acute leukemia after azathioprine treatment of connective tissue disease.

  1977cited by this paper
• Acute myelogenous leukemia in two patients treated with azathioprine for nonmalignant diseases.

  1974cited by this paper

• Incidence, screening, and management of de novo malignancies in liver transplant patients: A review

  2025cites this paper
• Cutaneous Post-transplant Lymphoproliferative Disorder

  2024cites this paper
• A Pathology Experience of Posttransplant Lymphoproliferative Disorder From One Tertiary Hospital: Pathology Concepts and Diagnostic Approach

  2024cites this paper
• Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder

  2022cites this paper
• Gastrointestinal manifestations, risk factors, and management in patients with post-transplant lymphoproliferative disorder: A systematic review

  2022cites this paper
• Extrahepatic cancer risk after liver transplantation for hepatocellular carcinoma: incidence, risk and prevention

  2021cites this paper
• Safety and Efficacy of Anti-CD19-Chimeric Antigen Receptor T Cell Combined With Programmed Cell Death 1 Inhibitor Therapy in a Patient With Refractory Post-Transplant Lymphoproliferative Disease: Case Report and Literature Review

  2021influential citation
• Heterogeneous Manifestations of Posttransplant Lymphoma in Renal Transplant Recipients: A Case Series.

  2021cites this paper
• Lebertransplantation

  2020cites this paper
• Malignancy After Transplant

  2020cites this paper
• Post-transplant Lymphoproliferative Disorder in Recipient's Reconstructed Middle Hepatic Vein After Pediatric Living Donor Liver Transplant: A Case Report.

  2020cites this paper
• Survival outcomes of allogeneic hematopoietic cell transplants with EBV‐positive or EBV‐negative post‐transplant lymphoproliferative disorder, A CIBMTR study

  2019cites this paper
• Pathology of Kidney Transplantation

  2019cites this paper
• isolated primary central nervous system lymphoma renal transplant treated with surgical and pharmacologic intervention a case report and review of literature

  2019cites this paper
• Post-transplant malignancies in pediatric liver transplant recipients: Experience of two centers in Turkey.

  2018cites this paper
• Clinical characteristics and outcomes of PTLD following intestinal transplantation

  2018cites this paper
• A review of adenotonsillar hypertrophy and adenotonsillectomy in children after solid organ transplantation.

  2018cites this paper
• The changing face of adult posttransplant lymphoproliferative disorder: Changes in histology between 1999 and 2013

  2018cites this paper
• EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in ASXL1, BCOR, CDKN2A, NF1, and TP53

  2017cites this paper
• Risk-adapted Treatment for Severe B-Lineage Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation in Children

  2016cites this paper
• Incidence, risk factors and outcomes of de novo malignancies post liver transplantation.

  2016cites this paper
• Iatrogenic immunosuppression and risk of non‐Hodgkin lymphoma in solid organ transplantation: A population‐based cohort study in Australia

  2016cites this paper
• Iatrogenic immunodeficiency-associated lymphoproliferative disorders in transplant and nontransplant settings

  2016cites this paper
• Lymphoproliférations survenant après transplantation d’organes solides

  2016cites this paper
• Post-transplant lymphoproliferative disorders.

  2015cites this paper
• Lymphoproliferative Disorders after Lung Transplantation: Clinicopathological Characterization of 16 Cases with Identification of Very-Late-Onset Forms

  2015cites this paper
• Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis

  2015cites this paper
• Epstein-Barr Virus–Positive Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation: Pathogenesis, Clinical Manifestations, Diagnosis, and Management

  2015cites this paper
• II. Challenges in the management of post‐transplant lymphoproliferative disorder

  2015cites this paper
• The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder

  2015influential citation
• Epstein-Barr Virus-Negative Post-Transplant Lymphoproliferative Diseases: Three Distinct Cases from a Single Center

  2014cites this paper
• Long-term complete remission of multiple extranodal natural killer/T-cell-type posttransplant lymphoproliferative disorder after surgical resection: a case report.

  2014cites this paper
• Posttransplantation lymphoproliferative disease: proposed imaging classification.

  2014cites this paper
• Risk of diffuse large B‐cell lymphoma after solid organ transplantation in the United States

  2014cites this paper
• Posttransplant lymphoproliferative disorder following kidney transplant

  2014cites this paper
• Post‐transplant lymphoproliferative disorders are not associated with IgG4 sclerosing disease

  2014cites this paper
• Current status of immunosuppression in liver transplantation.

  2013cites this paper
• Early onset, EBV(-) PTLD in pediatric liver-small bowel transplantation recipients: a spectrum of plasma cell neoplasms with favorable prognosis.

  2013cites this paper
• Spectrum of lymphoproliferative disorders following renal transplantation in North India

  2013cites this paper
• Posttransplantation Lymphoproliferative Disorder in Lung Transplant Recipients: A 15-Year Single Institution Experience

  2013cites this paper
• T-cell therapy in the treatment of post-transplant lymphoproliferative disease

  2012cites this paper
• A rare case of primary cutaneous plasmacytoma‐like lymphoproliferative disorder following renal transplantation

  2012cites this paper
• Burden of de novo malignancy in the liver transplant recipient

  2012cites this paper
• Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases.

  2012cites this paper
• Multifocal cranial plasmablastic lymphoma as a rare manifestation of posttransplant lymphoproliferative disorder.

  2012cites this paper
• Post‐Transplant Lymphoproliferative Disorder and other Malignancies after Liver Transplantation

  2012cites this paper
• The Dawn of Clinical Medicine: Bronze Age Medical Practice in Egypt

  2012cites this paper
• Epstein-Barr Virus-Negative Post-Transplant Lymphoproliferative Diseases: Three Distinct Cases from a Single Center Epstein-Barr Virüs-Negatif Post-Transplant Lenfoproliferatif Hastalik: Tek Merkezden Üç Farkli Olgu

  2012cites this paper
• Fludarabine, cyclophosphamide, doxorubicin (FCD), and rituximab: A remission induction therapy for aggressive pediatric post‐transplant lymphoproliferative disease (PTLD)

  2011cites this paper
• Ocular adnexal non-Hodgkin’s lymphoma: a review of epidemiology and risk factors

  2011cites this paper
• Management of posttransplant lymphoproliferative disorders following solid organ transplant: an update

  2011cites this paper
• Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders

  2011cites this paper
• Time Trends in Risk and Risk Determinants of Non‐Hodgkin Lymphoma in Solid Organ Transplant Recipients

  2011influential citation
• disorders Molecular histogenesis of posttransplantation lymphoproliferative

  2011cites this paper
• Posttransplant lymphoproliferative disease following liver transplantation

  2011cites this paper
• Post‐transplant lymphoproliferative disorder following renal transplantation: A single‐center experience over 40 years

  2010cites this paper
• Device therapy and cardiac transplantation for end-stage heart failure.

  2010cites this paper
• Prevalence of posttransplantation lymphoproliferative disease in pediatric liver transplant recipients.

  2010cites this paper
• Formes pédiatriques rares

  2010cites this paper
• Post-transplant lymphoproliferative disorder after adult-to-adult living donor liver transplant: case series and review of literature

  2010cites this paper
• Significance of Epstein-Barr virus infection in the outcome of renal transplant patients with lymphoproliferative disorders.

  2010cites this paper
• Using Epstein-Barr Viral Load Assays To Diagnose, Monitor, and Prevent Posttransplant Lymphoproliferative Disorder

  2010cites this paper
• Cancer incidence and risk factors after solid organ transplantation

  2009cites this paper
• lifestyle, organ transplantation and genetic susceptibility

  2009cites this paper
• Malignancy After Heart Transplantation

  2009cites this paper
• Pediatric post-transplant lymphoproliferative disorder after cardiac transplantation

  2009cites this paper
• Post-transplant lymphoproliferative disorder localized in the colon after liver transplantation: Report of a case

  2009cites this paper
• Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation.

  2009cites this paper
• Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.

  2009cites this paper
• Molecular characterization of post‐transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients

  2009cites this paper
• De novo malignancy after solid organ transplantation in children.

  2009cites this paper
• Complications hématologiques malignes, en particulier lymphoprolifératives, après transplantation

  2008cites this paper
• Malignancy after solid organ transplantation: an overview.

  2008cites this paper
• Late-onset post-transplant lymphoproliferative disease presenting as massive occult gastrointestinal haemorrhage.

  2008cites this paper
• Rare Hematological Malignancies

  2008cites this paper
• Genetic and phenotypic analysis of B‐cell post‐transplant lymphoproliferative disorders provides insights into disease biology

  2008cites this paper
• Late‐onset Epstein–Barr virus‐negative post‐transplant lymphoproliferative disorder presenting as ulcerated necrotic papules and nodules in a renal transplant patient

  2008cites this paper
• Posttransplantation Lymphoproliferative Disorder

  2008cites this paper
• Posttransplant lymphoproliferative disorders.

  2008cites this paper
• A late-onset Epstein-Barr virus-related lymphoma completely remitted in a child with renal allograft.

  2007cites this paper
• General introduction and scope of the thesis

  2007cites this paper
• Role of Chemotherapy and Rituximab for Treatment of Posttransplant Lymphoproliferative Disorder in Solid Organ Transplantation

  2007cites this paper
• The management of posttransplant lymphoproliferative disorder

  2007cites this paper
• Case–control study of risk factors for the development of post‐transplant lymphoproliferative disease in a pediatric heart transplant cohort *

  2007cites this paper
• Letter to the Editor: “Burkitt Lymphoma in Renal Transplant Recipient”

  2007cites this paper
• Lymphoma in the immunosuppressed

  2007cites this paper
• Late occurrence of malignant post‐transplant lymphoproliferative disorder (PTLD) presenting with severe acute renal failure

  2007cites this paper
• Presentation and early detection of post‐transplant lymphoproliferative disorder after solid organ transplantation

  2007cites this paper
• and early detection of posttransplant lymphoproliferative disorder after solid organ transplantation

  2007cites this paper
• Transplantation: Posttransplant Lymphoproliferative Disorder

  2007cites this paper
• Post-transplant lymphoma of the pancreatic allograft in a kidney-pancreas transplant recipient: a misleading presentation.

  2006cites this paper
• [Hematologic malignant complications after transplantation].

  2006cites this paper
• Epstein-Barr Virus-negative posttransplant lymphoproliferative disorder with coexisting native renal cell carcinoma: PET/CT demonstration.

  2006cites this paper
• Simian virus 40 in posttransplant lymphoproliferative disorders.

  2006cites this paper
• Primary nonresponse to anti-cd20 therapy in gastrointestinal posttransplant lymphoproliferative disorder.

  2006cites this paper
• Chapter 34 – Lymphoma in the Immunosuppressed

  2006cites this paper
• Lymphoma after kidney transplantation: risk factors and timing of development

  2006cites this paper
• Post‐transplantation lymphoproliferative disorders localizing to the gastrointestinal tract after liver transplantation: Report of five pediatric cases

  2006cites this paper
• Post‐Transplant Lymphoproliferative Disorders Occurring After Renal Transplantation in Adults: Report of 230 Cases From the French Registry

  2006cites this paper
• Review of Epstein–Barr virus and post‐transplant lymphoproliferative disorder post‐solid organ transplantation (Review Article)

  2006cites this paper